Moderna
MRNA
#1188
Rank
โ‚ฌ14.51 B
Marketcap
37,72ย โ‚ฌ
Share price
-0.43%
Change (1 day)
-56.18%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ6.57 Billion

According to Moderna 's latest financial reports the company has โ‚ฌ6.57 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Moderna - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ7.78 B-15.69%
2022-12-31โ‚ฌ9.23 B-2.54%
2021-12-31โ‚ฌ9.47 B152.83%
2020-12-31โ‚ฌ3.74 B280.49%
2019-12-31โ‚ฌ0.98 B-25.96%
2018-12-31โ‚ฌ1.32 B111.07%
2017-12-31โ‚ฌ0.63 B-37.36%
2016-12-31โ‚ฌ1.00 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ83.6 M-98.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.97 B 112.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.97 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.66 B-59.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.42 B 104.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ0.65 B-90.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.43 B 195.57%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA